About Star Imaging and Path Lab Limited
Data last updated:
Star Imaging and Path Lab Limited is a public limited company based in New Delhi, Delhi, India. It operates in the diagnostic centers and pathology labs segment of the healthcare sector. It was incorporated on 31 May 2004 and has been in existence for over 22 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN L85110DL2004PLC126679. The company has 2 GST registrations on record, none of which is active. It is a listed company.
The company has an authorised share capital of ₹25 Cr and a paid-up capital of ₹17.42 Cr. It is led by directors including Pawan Gupta (Managing Director) and Vimal Kumar Gupta.
Its last annual general meeting (AGM) was held on 24 July 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 4B/4 Tilak Nagar Near Sant Pura, New Delhi, Delhi, India – 110018.
As per the latest consolidated financials for FY 2025-26, the company reported a revenue of ₹88.53 Cr, a growth of 6% compared to the previous year. For the same year it recorded a net profit of ₹19.29 Cr (net margin 21.8%) and EBITDA of ₹33.17 Cr (EBITDA margin 37.5%). The net worth stands at ₹116.1 Cr (up 146.2% YoY). Total assets are valued at ₹137.66 Cr (up 70.4% YoY).
The company has about 13 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹23.8 Cr and satisfied charges of ₹38.68 Cr on record. Court records list 5 cases involving the company, including 4 filed by the company and 1 filed against it; 1 case is pending. The company has 9 deals on record (3 secondary share transfers, 3 market trades, 2 funding rounds), with disclosed funding of ₹1.49 Cr; the latest was in June 2026. Its 10 peer companies in the Healthcare industry (Diagnostics and Pathology Labs) are compared by revenue, 5 larger and 5 smaller; the largest is Universal Medicap Limited with revenue of ₹91.31 Cr.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website starimaging.in.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social Media
- Registered Address4B/4 Tilak Nagar Near Sant Pura, New Delhi, Delhi, India – 110018
- IndustryHealthcare, Diagnostic Centers & Pathology Labs
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Star Imaging and Path Lab Limited
The main business activity of Star Imaging and Path Lab is hospital and medical care. In detail, this covers other hospital and medical care activities.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Star Imaging and Path Lab Limited FY 2025-26 filings available
Star Imaging and Path Lab Limited reported revenue of ₹88.53 Cr (up 6% YoY) for FY 2025-26.
Financial Highlights
FY 2025-26 · ConsolidatedRevenue vs Net Profit ₹ Cr
Margin trends
Financial summary ₹ Cr
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | 88.53 | 83.50 | 78.78 | 58.53 | 69.09 |
| Revenue growth | +6.0% | +6.0% | +34.6% | -15.3% | - |
| EBITDA | 33.17 | 29.34 | 23.19 | 6.05 | 14.70 |
| EBITDA margin | +37.5% | +35.1% | +29.4% | +10.3% | +21.3% |
| Profit before tax | 26.27 | 21.44 | 16.12 | 0.89 | 9.40 |
| Net profit | 19.29 | 15.94 | 11.66 | 0.58 | 6.30 |
| Net profit margin | +21.8% | +19.1% | +14.8% | +1.0% | +9.1% |
| EPS (₹) | 11.05 | 11.80 | 82.78 | 3.86 | 41.94 |
| Balance sheet | |||||
| Total assets | 138 | 80.79 | 62.83 | 46.32 | 48.62 |
| Net worth | 116 | 47.15 | 31.35 | 18.93 | 18.36 |
| Total debt | 20.67 | 32.74 | 30.63 | 26.56 | 29.57 |
| Cash & bank | 51.61 | 5.35 | 15.71 | 2.35 | 9.05 |
| Net working capital | 100 | 50.94 | 35.51 | 12.40 | 23.19 |
| Cash flow | |||||
| Cash from operations | 23.34 | (2.63) | 18.34 | 5.27 | 14.40 |
| Cash from investing | (12.75) | (7.36) | (6.87) | (7.22) | (4.14) |
| Cash from financing | 35.67 | (0.37) | 1.89 | (4.74) | (6.98) |
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | 88.53 | 83.24 | 78.50 | 58.37 | 68.94 |
| Revenue growth | +6.4% | +6.0% | +34.5% | -15.3% | - |
| EBITDA | 33.23 | 28.56 | 22.52 | 6.02 | 14.68 |
| EBITDA margin | +37.5% | +34.3% | +28.7% | +10.3% | +21.3% |
| Profit before tax | 26.33 | 21.34 | 16.01 | 0.87 | 9.41 |
| Net profit | 19.33 | 15.92 | 11.59 | 0.57 | 6.31 |
| Net profit margin | +21.8% | +19.1% | +14.8% | +1.0% | +9.2% |
| EPS (₹) | 11.09 | 11.79 | 82.25 | 3.82 | 42.01 |
| Balance sheet | |||||
| Total assets | - | 80.62 | 62.70 | 46.30 | 48.56 |
| Net worth | - | 47.06 | 31.27 | 18.93 | 18.36 |
| Total debt | - | 32.74 | 30.63 | 26.56 | 29.52 |
| Cash & bank | - | 5.14 | 15.44 | 2.18 | 8.97 |
| Net working capital | - | 50.74 | 35.37 | 12.39 | 23.12 |
| Cash flow | |||||
| Cash from operations | 23.44 | (2.49) | 18.25 | 6.47 | 14.39 |
| Cash from investing | (12.75) | (7.44) | (6.87) | (8.57) | (4.14) |
| Cash from financing | 35.67 | (0.37) | 1.89 | (4.70) | (6.99) |
Financial Statements
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|---|
| Revenue | 88.53 | 83.50 | 78.78 | 58.53 | 69.09 |
| Revenue growth | +6.0% | +6.0% | +34.6% | -15.3% | - |
| Other income | 1.00 | 0.29 | 1.19 | 0.15 | 0.18 |
| Total expenses | 55.36 | 54.16 | 55.59 | 52.48 | 54.39 |
| Employee cost | 0.00 | 7.49 | 7.24 | 8.31 | 8.90 |
| EBITDA | 33.17 | 29.34 | 23.19 | 6.05 | 14.70 |
| EBITDA margin | +37.5% | +35.1% | +29.4% | +10.3% | +21.3% |
| Depreciation | 5.93 | 4.96 | 5.24 | 3.34 | 3.53 |
| Interest | 1.97 | 3.23 | 3.02 | 1.97 | 1.95 |
| Profit before tax | 26.27 | 21.44 | 16.12 | 0.89 | 9.40 |
| Tax | 7.00 | 5.47 | 3.66 | 0.31 | 3.09 |
| Net profit | 19.29 | 15.94 | 11.66 | 0.58 | 6.30 |
| Net profit margin | +21.8% | +19.1% | +14.8% | +1.0% | +9.1% |
| EPS (₹) | 11.05 | 11.80 | 82.78 | 3.86 | 41.94 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|---|
| Equity & liabilities | |||||
| Share capital | 17.42 | 13.50 | 1.50 | 1.50 | 1.50 |
| Reserves & surplus | 98.68 | 33.65 | 29.85 | 17.43 | 16.86 |
| Shareholders' funds (net worth) | 116 | 47.15 | 31.35 | 18.93 | 18.36 |
| Minority interest | 0.05 | 0.08 | 0.05 | 0.01 | 0.01 |
| Secured loans | 5.70 | 13.65 | 11.41 | 10.75 | 11.74 |
| Unsecured loans | 14.97 | 19.09 | 19.22 | 15.81 | 17.83 |
| Total debt | 20.67 | 32.74 | 30.63 | 26.56 | 29.57 |
| Total liabilities | 138 | 80.79 | 62.83 | 46.32 | 48.62 |
| Assets | |||||
| Gross block | 78.71 | 68.47 | 64.35 | 56.41 | 49.11 |
| Net block | 25.22 | 20.91 | 21.70 | 19.01 | 15.05 |
| Capital work in progress | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Inventories | 0.38 | 0.24 | 0.53 | 0.63 | 0.08 |
| Sundry debtors | 49.93 | 50.76 | 32.64 | 17.61 | 16.16 |
| Cash & bank balances | 51.61 | 5.35 | 15.71 | 2.35 | 9.05 |
| Loans & advances | 12.88 | 10.89 | 4.39 | 5.56 | 6.30 |
| Total current assets | 115 | 67.24 | 53.27 | 26.15 | 31.59 |
| Total current liabilities | 14.64 | 16.30 | 17.76 | 13.75 | 8.40 |
| Net working capital | 100 | 50.94 | 35.51 | 12.40 | 23.19 |
| Total assets | 138 | 80.79 | 62.83 | 46.32 | 48.62 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|---|
| Opening cash | 5.35 | 15.71 | 2.35 | 9.05 | 5.77 |
| Net cash from operating activities | 23.34 | (2.63) | 18.34 | 5.27 | 14.40 |
| Net cash from investing activities | (12.75) | (7.36) | (6.87) | (7.22) | (4.14) |
| Net cash from financing activities | 35.67 | (0.37) | 1.89 | (4.74) | (6.98) |
| Net change in cash | 46.26 | (10.37) | 13.36 | (6.69) | 3.28 |
| Closing cash | 51.61 | 5.35 | 15.71 | 2.35 | 9.05 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|---|
| Growth | |||||
| Sales growth | +6.0% | +6.0% | +34.6% | -15.3% | - |
| EBITDA growth | +13.1% | +26.5% | +283.3% | -58.8% | - |
| PBT growth | +22.5% | +33.0% | +1711.2% | -90.5% | +9997.0% |
| Net income growth | +21.0% | +36.7% | +1910.3% | -90.8% | - |
| Revenue CAGR (3Y) | +14.8% | +6.5% | - | - | - |
| EBITDA CAGR (3Y) | +76.3% | +25.9% | - | - | - |
| Profitability & leverage | |||||
| Net income margin | +21.8% | +19.1% | +15.8% | +1.0% | +9.1% |
| Return on capital employed | - | +34.4% | +35.1% | +6.0% | +23.3% |
| Return on net worth | - | +40.7% | +49.5% | +3.1% | +34.3% |
| Debt / equity | - | 0.81 | 1.14 | 1.50 | 1.61 |
| Long-term debt / equity | - | 0.39 | 0.60 | 0.83 | 0.91 |
| Interest cover | 7.23 | 13.25 | 16.82 | 72.69 | 17.46 |
| Efficiency & per share | |||||
| Fixed asset turnover | - | 1.26 | 1.30 | 1.11 | 1.41 |
| Inventory turnover | - | 216.88 | 135.83 | 164.87 | 863.63 |
| Debtors turnover | - | 2.00 | 3.14 | 3.47 | 4.28 |
| EPS (₹) | 11.05 | 11.80 | 82.78 | 3.86 | 41.94 |
| Dividend per share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Book value per share (₹) | 0.00 | 34.93 | 209.01 | 126.23 | 122.37 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|---|
| Revenue | 88.53 | 83.24 | 78.50 | 58.37 | 68.94 |
| Revenue growth | +6.4% | +6.0% | +34.5% | -15.3% | - |
| Other income | 1.00 | 0.29 | 1.19 | 0.15 | 0.18 |
| Total expenses | 55.30 | 54.68 | 55.98 | 52.35 | 54.26 |
| Employee cost | 0.00 | 7.49 | 7.24 | 8.31 | 8.90 |
| EBITDA | 33.23 | 28.56 | 22.52 | 6.02 | 14.68 |
| EBITDA margin | +37.5% | +34.3% | +28.7% | +10.3% | +21.3% |
| Depreciation | 5.93 | 4.96 | 5.24 | 3.34 | 3.51 |
| Interest | 1.97 | 2.55 | 2.46 | 1.96 | 1.94 |
| Profit before tax | 26.33 | 21.34 | 16.01 | 0.87 | 9.41 |
| Tax | 7.00 | 5.42 | 3.66 | 0.30 | 3.09 |
| Net profit | 19.33 | 15.92 | 11.59 | 0.57 | 6.31 |
| Net profit margin | +21.8% | +19.1% | +14.8% | +1.0% | +9.2% |
| EPS (₹) | 11.09 | 11.79 | 82.25 | 3.82 | 42.01 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|---|
| Equity & liabilities | |||||
| Share capital | - | 13.50 | 1.50 | 1.50 | 1.50 |
| Reserves & surplus | - | 33.56 | 29.77 | 17.43 | 16.86 |
| Shareholders' funds (net worth) | - | 47.06 | 31.27 | 18.93 | 18.36 |
| Secured loans | - | 13.65 | 11.41 | 10.75 | 11.74 |
| Unsecured loans | - | 19.09 | 19.22 | 15.81 | 17.78 |
| Total debt | - | 32.74 | 30.63 | 26.56 | 29.52 |
| Total liabilities | - | 80.62 | 62.70 | 46.30 | 48.56 |
| Assets | |||||
| Gross block | - | 68.46 | 64.35 | 56.41 | 49.11 |
| Net block | - | 20.93 | 21.72 | 19.02 | 15.06 |
| Capital work in progress | - | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | - | 0.01 | 0.01 | 0.01 | 0.01 |
| Inventories | - | 0.24 | 0.53 | 0.63 | 0.08 |
| Sundry debtors | - | 50.69 | 32.58 | 17.58 | 16.16 |
| Cash & bank balances | - | 5.14 | 15.44 | 2.18 | 8.97 |
| Loans & advances | - | 10.89 | 4.39 | 5.56 | 6.30 |
| Total current assets | - | 66.96 | 52.94 | 25.95 | 31.51 |
| Total current liabilities | - | 16.22 | 17.57 | 13.56 | 8.39 |
| Net working capital | - | 50.74 | 35.37 | 12.39 | 23.12 |
| Total assets | - | 80.62 | 62.70 | 46.30 | 48.56 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|---|
| Opening cash | 5.14 | 15.44 | 2.18 | 8.97 | 5.71 |
| Net cash from operating activities | 23.44 | (2.49) | 18.25 | 6.47 | 14.39 |
| Net cash from investing activities | (12.75) | (7.44) | (6.87) | (8.57) | (4.14) |
| Net cash from financing activities | 35.67 | (0.37) | 1.89 | (4.70) | (6.99) |
| Net change in cash | 46.36 | (10.30) | 13.27 | (6.80) | 3.26 |
| Closing cash | 51.51 | 5.14 | 15.44 | 2.18 | 8.97 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|---|
| Growth | |||||
| Sales growth | +6.4% | +6.0% | +34.5% | -15.3% | - |
| EBITDA growth | +16.4% | +26.8% | +274.1% | -59.0% | - |
| PBT growth | +23.4% | +33.3% | +1740.2% | -90.8% | +9997.0% |
| Net income growth | +21.4% | +37.4% | +1933.3% | -91.0% | - |
| Revenue CAGR (3Y) | +14.9% | +6.5% | - | - | - |
| EBITDA CAGR (3Y) | +76.7% | +24.8% | - | - | - |
| Profitability & leverage | |||||
| Net income margin | +21.8% | +19.1% | +15.7% | +1.0% | +9.2% |
| Return on capital employed | - | +33.3% | +33.9% | +6.0% | +23.3% |
| Return on net worth | - | +40.6% | +49.2% | +3.1% | +34.3% |
| Debt / equity | - | 0.81 | 1.14 | 1.50 | 1.61 |
| Long-term debt / equity | - | 0.39 | 0.60 | 0.83 | 0.90 |
| Interest cover | 7.22 | 10.81 | 14.24 | 73.13 | 17.37 |
| Efficiency & per share | |||||
| Fixed asset turnover | - | 1.25 | 1.30 | 1.11 | 1.40 |
| Inventory turnover | - | 216.21 | 135.34 | 164.42 | 861.75 |
| Debtors turnover | - | 2.00 | 3.13 | 3.46 | 4.27 |
| EPS (₹) | 11.09 | 11.79 | 82.25 | 3.82 | 42.01 |
| Dividend per share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Book value per share (₹) | 0.00 | 34.86 | 208.46 | 126.21 | 122.38 |
Peer Comparison of Star Imaging and Path Lab Limited
Star Imaging and Path Lab Limited is compared with the companies closest to it by revenue in the Healthcare industry (Diagnostics and Pathology Labs). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Universal Medicap Limited | ₹91.31 Cr (FY 2025) | •••• | •••• | 18.0% | •••• | Vadodara, Gujarat, India |
| Star Imaging and Path Lab Limited this company | ₹88.53 Cr (FY 2026) | •••• | •••• | 6.0% | •••• | New Delhi, Delhi, India |
| Konnect Imaging and Diagnostics Private Limited | ₹86.55 Cr (FY 2025) | •••• | •••• | 20.0% | •••• | Hyderabad, Telangana, India |
| Atulaya Healthcare Private Limited | ₹85.65 Cr (FY 2024) | •••• | •••• | 21.0% | •••• | Chandigarh, India |
| Dr Dangs Lab LLP | ₹85.08 Cr (FY 2025) | •••• | •••• | 26.0% | •••• | New Delhi, Delhi, India |
| Dishari Health Point Private Limited | ₹84.83 Cr (FY 2024) | •••• | •••• | 28.0% | •••• | Malda, West Bengal, India |
| General Diagnostics International Private Limited | ₹83.11 Cr (FY 2025) | •••• | •••• | 57.0% | •••• | Navi Mumbai, Maharashtra, India |
| Pulse Diagnostics Private Limited | ₹80.71 Cr (FY 2024) | •••• | •••• | 27.0% | •••• | Kolkata, West Bengal, India |
| Modern Diagnostic & Research Centre Limited | ₹78.8 Cr (FY 2025) | •••• | •••• | 15.0% | •••• | New Delhi, Delhi, India |
| Industrial X-Rayandallied Radiographers(India)Pvt Ltd | ₹78.51 Cr (FY 2025) | •••• | •••• | •••• | Mumbai, Maharashtra, India | |
| Sanghi Medical Centre Private Limited | ₹77.91 Cr (FY 2025) | •••• | •••• | 16.0% | •••• | New Delhi, Delhi, India |
Peers are the five companies nearest above and the five nearest below Star Imaging and Path Lab by revenue in the Healthcare industry (Diagnostics and Pathology Labs), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Board of Directors of Star Imaging and Path Lab Limited
Star Imaging and Path Lab has 7 current directors and 12 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vimal Kumar Gupta Also directs: Sunrise Heritage LLP, Abyss Pharma Private Limited | Director | 01 Jul 2024 | 2 Years 3 Months | Current |
| Dikshant Nagpal Also directs: Star Forresta LLP, Futurity Sustainable Foods Private Limited, Unilync Soft-Tech Private Limited and 1 more | Director | 30 Nov 2024 | 1 Years 10 Months | Current |
| Chhaya Gupta Also directs: Staredu Education and Training Institute Private Limited | Director | 20 Mar 2024 | 2 Years 6 Months | Current |
| Pawan Gupta | Managing Director | 31 May 2004 | 22 Years 4 Months | Current |
| Neelam Ratra | Director | 16 Jun 2025 | 1 Years 3 Months | Current |
| Yogesh Kumar Virmani | Director | 01 Jul 2024 | 2 Years 3 Months | Current |
Charges & Borrowings of Star Imaging and Path Lab Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Apr 2026 | Hdfc Bank Limited | ₹22.92 Lakh | Open |
| 24 Sep 2025 | Hdfc Bank Limited | ₹11.46 Lakh | Open |
| 02 May 2025 | Hdfc Bank Limited | ₹13.71 Lakh | Open |
| 24 Mar 2025 | Others | ₹4.32 Cr | Open |
| 15 Sep 2023 | Hdfc Bank Limited | ₹7.6 Lakh | Open |
Total charge records: 28 View all charges
Deals & Funding of Star Imaging and Path Lab Limited
Star Imaging and Path Lab Limited has 9 deals on record (3 secondary share transfers, 3 market trades, 2 funding rounds), with disclosed funding of ₹1.49 Cr; the latest was in June 2026.
Deals on record (5 of 9)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Jun 2026 | Market trade | ₹90.5 Lakh | Buyer: an individual |
| Sep 2025 | Market trade | ₹2.9 Cr | Seller: Strategic Sixth Sense Capital Fund |
| Aug 2025 | Market trade | ₹3.29 Cr | Buyer: Share India Securities Limited, Achintya Securities Limited Seller: Share India Securities Limited |
| Aug 2025 | IPO | ₹69.47 Cr | Investors: Mili Capital Investement, Compact Structure Fund, Persistent Growth Fund Seller: an individual |
| Jul 2025 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
Full deal history
All 9 deals with amounts, valuations, instruments and every party are in the company report.
- Every funding round and share transfer
- Amounts and valuations
- Investors, buyers and sellers
- Instruments and deal dates
Verified entity values are shown only after access is granted.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal Cases of Star Imaging and Path Lab Limited
Star Imaging and Path Lab Limited has 5 court cases on record: 4 filed by Star Imaging and Path Lab, 1 filed against it. 1 case is pending and 4 are disposed. Status as checked between 21 Sep 2026 and 03 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 5 | 1 | 1 |
Cases on record (5 of 5)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, New Delhi, Delhi | Criminal case | Filed by the company against Ugam Healthcare Private Limited | Pending |
| District court, South West, Delhi | Cheque dishonour complaint | Filed by the company against Ugam Healthcare Private Limited | Disposed |
| District court, West, Delhi | Civil suit | Filed against the company by Aone Copier Services Private Limited | Disposed |
| District court, Central, Delhi | Interim or miscellaneous application | Filed by the company against an individual | Disposed |
| District court, Central, Delhi | Interim or miscellaneous application | Filed by the company against an individual | Disposed |
Full case history
All 5 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance at Star Imaging and Path Lab Limited
Employment history and EPFO contributions of people linked to Star Imaging and Path Lab.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
CIN History of Star Imaging and Path Lab Limited
Star Imaging and Path Lab has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is L85110DL2004PLC126679, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| L85110DL2004PLC126679 | Current |
| U85110DL2004PLC126679 | Previous |
| U85110DL2004PTC126679 | Previous |
News related to Star Imaging and Path Lab Limited
Recent Activity on Star Imaging and Path Lab Limited
Star Imaging and Path Lab Limited has 19 board changes on record since 2004: 7 appointments and 12 cessations. The latest: Neelam Ratra ceased to be Additional Director on 24 Jun 2025.
59 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Star Imaging and Path Lab Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Star Imaging and Path Lab Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Star Imaging and Path Lab Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Star Imaging and Path Lab Limited
Star Imaging and Path Lab has 2 GST registrations on record, and all of them have been cancelled or are inactive. Only active GST numbers are listed on this page.
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Star Imaging and Path Lab Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Star Imaging and Path Lab Limited
Star Imaging and Path Lab is an active public limited company based in New Delhi, Delhi, India. The company works in diagnostic centers and pathology labs, within the healthcare industry. It was incorporated on 31 May 2004 (22+ years old) and is registered under CIN L85110DL2004PLC126679.
Star Imaging and Path Lab reported revenue of ₹88.53 Cr for FY 2025-26 (up 6% YoY) based on consolidated financials.
Star Imaging and Path Lab has 7 current directors:
- Pawan Gupta - Managing Director
- Vimal Kumar Gupta - Director
- Dikshant Nagpal - Director
- Chhaya Gupta - Director
- Neelam Ratra - Director
- Yogesh Kumar Virmani - Director
- Sameer Sood - Director
No. Star Imaging and Path Lab has 2 GST registrations on record and all of them are cancelled or inactive.
The CIN (Corporate Identification Number) of Star Imaging and Path Lab is L85110DL2004PLC126679. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Yes, Star Imaging and Path Lab is a listed company.
Star Imaging and Path Lab has 5 court cases on record: 4 filed by the company and 1 filed against it. 1 is pending.
Star Imaging and Path Lab was incorporated on 31 May 2004, making it 22+ years old. It is registered with the Registrar of Companies, Delhi.
Star Imaging and Path Lab has 9 deals on record (3 secondary share transfers, 3 market trades, 2 funding rounds), with disclosed funding of ₹1.49 Cr; the latest was in June 2026.
The peers of Star Imaging and Path Lab by revenue are Universal Medicap Limited, Konnect Imaging and Diagnostics Private Limited, Atulaya Healthcare Private Limited, Dr Dangs Lab LLP, Dishari Health Point Private Limited and 5 more, all in the Healthcare industry (Diagnostics and Pathology Labs).
Neelam Ratra ceased to be Additional Director on 24 Jun 2025. Neelam Ratra was appointed as Director on 16 Jun 2025. Sameer Bhati ceased to be Director on 13 Jun 2025. Star Imaging and Path Lab has 19 board changes on record in total.